DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report
DENVER, May 14, 2024 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new standard for health care services. DaVita's annual Community Care Report examines progress toward its 2025 Environmental, Social, and Governance (ESG) goals to help improve the lives of patients and support the health of communities globally.
The report highlights 2023 milestones across five strategic focus areas:
Patient Care
Teammate Engagement
Environmental Stewardship
Healthy Communities
Leading with Integrity and Accountability
"The sustained progress outlined in this report underscores our vision for an unwavering pursuit of a healthier tomorrow," said Javier Rodriguez, chief executive officer for DaVita. "Building a healthier tomorrow begins with excellence in patient care and extends to our positive impact on the communities we serve. I'm proud to work alongside dedicated teammates who are deeply committed to uplifting our patients, each other and our world."
Following are 2023 standout achievements from each of the five focus areas reflected in the report.
Patient Care
8,000+ DaVita patients received a kidney transplant, the provider's highest number of annual transplants to date
37,000+ people participated in Kidney Smart®, DaVita's award-winning kidney disease education program, which is available in more than ten languages
DaVita conducted unique health equity and social determinants of health pilot programs across the country focused on transplant equity and community-based chronic kidney disease education
DaVita launched Mozarc Medical with Medtronic, a new kidney health technology company dedicated to improving access to home dialysis
Teammate Engagement
49,000+ clinical teammates are a part of DaVita's innovative career pathways program, Clinical Ladders
2,300+ teammates are pursuing or have received their nursing degree, funded by DaVita, as part of its Bridge to Your Dreams program
~60% of DaVita facility administrators and managers have been promoted internally
Operational managers who lead DaVita's dialysis centers are 78% women and 40% people of color
Environmental Stewardship
DaVita's virtual power purchase agreements continued to produce enough renewable energy to power 100% of its U.S. operations
More than 100 million gallons of water were saved through water efficiency projects
DaVita became the only North American health care provider to receive a CDP climate change score in the highest "Leadership" category, with a score of "A-"
Healthy Communities
The 2023 DaVita Health Tour provided thousands of community members across the country with free health screenings and education focused on kidney health
DaVita teammates recorded 43,000+ volunteer hours, contributing to a record-setting year for volunteerism
DaVita and the American Diabetes Association collaborated to provide educational content aimed at helping those living with diabetes prevent and manage kidney disease
Through support from the DaVita Giving Foundation, the Food is Medicine Coalition provided more than 140,000 medically tailored meals to people with food insecurity and medical nutrition needs, including individuals living with end stage kidney disease
Leading with Integrity & Accountability
99.9% of DaVita teammates completed annual compliance training in 2023, contributing to more than 90,000 hours dedicated to compliance learning and development
To learn more about DaVita's vision for corporate citizenship or to download the full report, visit DaVita.com/CommunityCare.
Forward Looking Statements: This press release contains or refers to certain forward-looking statements within the meaning of the federal securities laws including, among other things. Without limiting the foregoing, statements including the words "expect," "intend," "will," "may," "continue," "target," "goal" and similar expressions are intended to identify forward-looking statements. The Company bases its forward-looking statements on information available to it on the date of this press release, and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may otherwise be required by law. Actual future events could also differ materially due to numerous factors that involve substantial known and unknown risks and uncertainties including, among other things, the risks and uncertainties set forth under "Risk Factors" and elsewhere in the Company's reports on Form 10-K and Form 10-Q and the other risks and uncertainties discussed in any subsequent reports that the Company files with the Securities and Exchange Commission from time to time.
About DaVita Inc. DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey?from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2024, DaVita served approximately 258,600 patients at 3,092 outpatient dialysis centers, of which 2,665 centers were located in the United States and 427 centers were located in 12 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Report on how AI is redefining market landscape - The healthcare services market and it is set to grow by USD 6.26 trillion from 2024 to 2028. However, the growth momentum will progressing at a CAGR of 8.73% during the forecast period, according to...
Bioretec Ltd has today published its 2024 Financial Statements and Report by the Board of Directors. The publications are attached to this release and also available in Finnish and English on the company's website at...
The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion in 2024 and an impressive US$3.05 billion by 2029. Market growth is attributed to rising investments in cell...
American Injectables, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, recently announced strategic leadership appointments to position the company for continued growth in 2025 and beyond....
VoiceCare AI, a healthcare administration general intelligence (HAGI) company, announced plans to automate back-office conversations and super-staff the workforce through the application of generative AI. The company's agentic architecture platform...
A new fertility technology from Tel Aviv University has increased IVF success rates from 34% to 65% by selecting sperm with optimal genetic health. Dr. Lorne Brown, Clinical Director at Acubalance, stresses the importance of male fertility, noting...